INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Sasha Latypova confirms EU regulators had major concerns over the jabs—pressure from above overruled them anyway

Sasha Latypova confirms EU regulators had major concerns over the jabs—pressure from above overruled them anyway

Hedley Rees's avatar
Hedley Rees
Jul 28, 2022
∙ Paid
3

Share this post

INSIDE PHARMA
INSIDE PHARMA
Sasha Latypova confirms EU regulators had major concerns over the jabs—pressure from above overruled them anyway
Share

Who is Sasha Latypova?

Many subscribers to INSIDE PHARMA will be familiar with Sasha Latypova. For those who are new to Sasha’s work, this is her first interview, which is very, very revealing:

INSIDE PHARMA
SASHA LATYPOVA CALLS FOR EMA STAFF TO DO THE RIGHT THING
WHO IS SASHA LATYPOVA? Sasha Latypova built two businesses in pharma over 20+ years, supporting companies like Pfizer and J&J in running clinical trials. She sold both businesses, and in 2014, retired to spend more time on the ski slopes. Fast-forward to 2020, and SARS-CoV-2 drags her back into an industry she thought she had waved goodbye to forever. Tha…
Read more
3 years ago · 6 likes · 5 comments · Hedley Rees

The first thing to note is that she has absolutely no incentive to spread ‘fake news’, as they call it. Her work is purely in the name of keeping patients safe from medical interventions that are totally novel and untested.

That made Sasha the ideal candidate to spread the expert knowledge I mentioned in a recent post:

INSIDE PHARMA
Time to become a Pharma Insider? Only expert knowledge of the industry will sort things out
The COVID scam worked due to lack of public knowledge It’s become increasingly clear that those planning and executing the COVID ‘vaccine’ scam were only able to do it because so many outside the pharma did not know it’s inner workings. That was compounded, of course, by the entire industry keeping deadly silent on the long-standing laws and processes put…
Read more
3 years ago · 9 likes · 7 comments · Hedley Rees

What was the gist of Sasha’s interview?

In summary, Sasha confirmed, from the vast collection of documents provided by her industry contacts, that the early Pfizer injections manufactured and supplied were ‘experimental’.

She also explained the huge scientific, technical and logistics complications involved in the process of production, and the various risks presented. These were identified as major issues by the European Medicines Agency in the Rolling Review documentation.

However, those batches so produced were shipped to patients anyway, in spite of the major objections from Europe’s Competent Authority responsible for the licensing of medicines.

There’s more, much more of course. Be assured also, that although this is for paid subscribers only, this interview will be shared with the various lawyers and other interested parties that Hedley and Sasha have been working with over the last 12+ months to get the truth to where it needs to get.

This is the interview (note: the next insider on my list is Brook Jackson, stay tuned):

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share